Mondaq All Regions - India: Food, Drugs, Healthcare, Life Sciences
Singh & Associates
Besremi was designated as an orphan medicinal product on December 09, 2011.
Singh & Associates
The Central Government, with an aim to offer medicines/healthcare products at affordable prices to the public, has taken a number of measures ranging from making drugs available through Jan Aushadhi stores ...
Singh & Associates
In a landmark decision, the Lok Sabha, on January 08, 2019, passed the "DNA Technology (Use and Application) Regulation Bill - 20193" (here after referred as "Bill").
Khurana and Khurana
The recommendations have faced a lot of backlash from multinational pharmaceutical companies.
Nishith Desai Associates
Madras High Court has ordered the government to ensure that no prescription medicine is sold online without a license
Singh & Associates
The first dose may be given as early as 6 weeks of age.
Singh & Associates
The FDA also granted Breakthrough Therapy designation, Orphan Drug designation and Priority Review designation to Elzonris.
Singh & Associates
On December 13, 2018, the Central Government announced ban on the use of drug Buclizine (a appetite stimulant) which was found to be irrational for the human use.
Singh & Associates
On December 19, 2018, the CDSCO re-issued safety guidelines for ‘Isotretinoin' following public grievances related to drug's Adverse Drugs Reaction received at Centralized Public Grievance Redress and Monitoring System.
Singh & Associates
Recently, there was a huge debate going-on both at the state and center level regarding online sales of the medicine.
Singh & Associates
Central Drugs Standard Control Organization, in coordination with concerned State Licensing Authority for action as per the provisions of Drugs & Cosmetics Act, 1940, and the Drugs & Cosmetics Rules, 1945, ...
SKP Business Consulting LLP
Digital innovation, driven by Artificial Intelligence (AI) will undoubtedly bring the next wave of significant disruption to the healthcare industry, impacting organizations in myriad ways.
Nishith Desai Associates
The Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) has notified an order amending the Drugs (Prices Control) Order 2013.
SKP Business Consulting LLP
On Friday 25 January 2019, the Prime Minister of India forecasted that "New India" is on the way to becoming the fifth largest economy in the world.
Phoenix Legal
Amidst the on-going heated debate on expanding the scope of the pharmaceuticals and medical devices being subject to price control, the Department of Pharmaceuticals recently notified certain exemptions ...
Cyril Amarchand Mangaldas
The Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) vide notification G.S.R. 1230(E) on December 21, 2018 ...
Nishith Desai Associates
Radiant Life Care Private Limited, a leading Indian hospital management company promoted by Mr. Abhay Soi and backed by global investment firm KKR announced that its shareholders, through series of transactions, ...
LexOrbis
The new amendment in DPCO also exempts drugs for orphan diseases also known as orphan drugs from the price control mechanism.
Singh & Associates
The FDA-reviewed products are currently being used to treat over 14 million HIV patients globally.
Khurana and Khurana
Non-patent exclusivity or Regulatory exclusivity is the core profit driver of the pharma industry.
Latest Video
Most Popular Recent Articles
Khaitan & Co
The e-commerce sector has grown exponentially over the last decade and has revolutionised the interplay between internet and commerce worldwide.
Singh & Associates
The Indian Pharmacopoeia Commission (IPC) has released the Eighth Edition of Indian Pharmacopoeia (IP-2018). It was released by the Secretary, Ministry of Health & Family Welfare, Government of India.
Kochhar & Co.
The Legal Metrology (Packaged Commodities) Rules, 2011 ("Packaging Rules") regulate pre-packaged commodities in India and inter – alia mandate certain labeling requirements prior to sale of such commodities.
Khurana and Khurana
It cannot be debated that E-pharmacy cannot be equated with normal e-commerce platform.
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Singh & Associates
The license retention fee referred to in sub-rule (1), shall be equivalent to the respective fee required for the grant of such license excluding inspection fee paid for grant of license.
Khurana and Khurana
Non-patent exclusivity or Regulatory exclusivity is the core profit driver of the pharma industry.
LexOrbis
The new amendment in DPCO also exempts drugs for orphan diseases also known as orphan drugs from the price control mechanism.
Cyril Amarchand Mangaldas
The Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) vide notification G.S.R. 1230(E) on December 21, 2018 ...
Nishith Desai Associates
Radiant Life Care Private Limited, a leading Indian hospital management company promoted by Mr. Abhay Soi and backed by global investment firm KKR announced that its shareholders, through series of transactions, ...
Phoenix Legal
Amidst the on-going heated debate on expanding the scope of the pharmaceuticals and medical devices being subject to price control, the Department of Pharmaceuticals recently notified certain exemptions ...
Khurana and Khurana
The Indian Pharmaceutical industry is one of the largest, ranked fourth in the world in respect to the production volume.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with